Latest News about ARGX
Recent news which mentions ARGX
Argenx Eyes Larger Patient Pool Following Expanded FDA Nod For Lead Drug For Neuromuscular Disease
May 11, 2026
From Benzinga
From Benzinga
Regeneron Advances In Rare Disease Race With Positive Autoimmune Muscle Disorder Trial Data
August 26, 2025
From Benzinga
Argenx Targets FDA Label Expansion After Vyvgart Trial Success
August 25, 2025
From Benzinga
From Benzinga
Earnings Scheduled For July 31, 2025
July 31, 2025
From Benzinga
From Benzinga
From Benzinga
From Benzinga
From Benzinga
From Benzinga
From Benzinga
With Trials In Motion, Cash To 2027, Can Kyverna's Next Data Drop Turn The Stock Around?
May 27, 2025
From Benzinga
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Earnings Scheduled For May 8, 2025
May 08, 2025
From Benzinga
A Look Into argenx Inc's Price Over Earnings
May 07, 2025
From Benzinga
P/E Ratio Insights for argenx
April 29, 2025
From Benzinga
From Benzinga
From Benzinga
FDA Approves Argenx's Vyvgart Hytrulo Prefilled Syringe For Self-Injection For At Home Use Setting
April 11, 2025
From Benzinga